170 related articles for article (PubMed ID: 9566119)
1. SH3 domains and drug design: ligands, structure, and biological function.
Dalgarno DC; Botfield MC; Rickles RJ
Biopolymers; 1997; 43(5):383-400. PubMed ID: 9566119
[TBL] [Abstract][Full Text] [Related]
2. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
4. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
[TBL] [Abstract][Full Text] [Related]
5. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
[TBL] [Abstract][Full Text] [Related]
6. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
Hiipakka M; Poikonen K; Saksela K
J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of PxxDY motif recognition in SH3 binding.
Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
9. Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions.
Fernandez-Ballester G; Beltrao P; Gonzalez JM; Song YH; Wilmanns M; Valencia A; Serrano L
J Mol Biol; 2009 May; 388(4):902-16. PubMed ID: 19324052
[TBL] [Abstract][Full Text] [Related]
10. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.
Batra-Safferling R; Granzin J; Mödder S; Hoffmann S; Willbold D
Biol Chem; 2010 Jan; 391(1):33-42. PubMed ID: 19919182
[TBL] [Abstract][Full Text] [Related]
11. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.
Brannetti B; Via A; Cestra G; Cesareni G; Helmer-Citterich M
J Mol Biol; 2000 Apr; 298(2):313-28. PubMed ID: 10764600
[TBL] [Abstract][Full Text] [Related]
12. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
Pisabarro MT; Serrano L
Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.
Tiwari R; Brown A; Narramaneni S; Sun G; Parang K
Biochimie; 2010 Sep; 92(9):1153-63. PubMed ID: 20109515
[TBL] [Abstract][Full Text] [Related]
14. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
15. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
[TBL] [Abstract][Full Text] [Related]
17. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
Hou T; McLaughlin W; Lu B; Chen K; Wang W
J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
[TBL] [Abstract][Full Text] [Related]
18. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
[TBL] [Abstract][Full Text] [Related]
19. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced strain in hydrogen bonds of the c-Src SH3 domain detected by NMR.
Cordier F; Wang C; Grzesiek S; Nicholson LK
J Mol Biol; 2000 Dec; 304(4):497-505. PubMed ID: 11099375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
